Kimberly Simmons, MD

home / authors / kimberly-simmons-md

Articles

Strategies to Improve Screening and Diagnosis of T1D

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 24th 2023

Drs Robert Busch, Robin S. Goland, Kimberly Simmons, and Teresa Quattrin discuss strategies to facilitate screening of type 1 diabetes and improve management of disease.

Managing T1D Comorbidities

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 24th 2023

Experts in endocrinology share their approach to managing type 1 diabetes along with related health conditions.

Investigational Therapies for the Management of T1D

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 17th 2023

Teresa Quattrin, MD, reviews emerging clinical trial data on novel therapies to delay the progression of type 1 diabetes.

Patient Monitoring After Teplizumab Therapy in T1D

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 17th 2023

Kimberly Simmons, MD, MPH/MSPH, leads a discussion on long-term monitoring for patients with type 1 diabetes and which providers are most likely to administer and manage teplizumab treatment.

Patient Selection for Teplizumab in T1D

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 13th 2023

Experts in endocrinology share their approach to patient selection for teplizumab in type 1 diabetes and the impact of a 2-year delay in the onset of the disease.

Safety and Efficacy of Teplizumab in T1D

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 13th 2023

Dr Kimberly Simmons reviews key findings from an initial study and extended follow-up on the safety and efficacy of teplizumab in delaying the progression of type 1 diabetes.

New Therapies to Delay T1D Progression

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 8th 2023

Robin S. Goland, MD, and Kimberly Simmons, MD, MPH/MSPH, provide insight on teplizumab, which was recently approved by the FDA, to delay the progression of type 1 diabetes, and they discuss the implications of autoantibody detection in patients.

Delaying Onset of T1D

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 8th 2023

Dr Teresa Quattrin discusses the significance of delaying the onset of type 1 diabetes.

Using Type 2 Diabetes Medications to Treat T1D

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 6th 2023

Teresa Quattrin, MD, leads a discussion on the benefits of using medications for type 2 diabetes to manage patients who have type 1 diabetes.

ADA Guidelines for Managing T1D

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 6th 2023

Kimberly Simmons, MD, MPH/MSPH, reviews ADA guidelines recommendations for the management of type 1 diabetes.

Screening and Diagnosis of T1D

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 3rd 2023

Dr Kimberly Simmons and Dr Teresa Quattrin examine the diagnostic process and importance of screening for type 1 diabetes.

Overview of Type 1 Diabetes (T1D)

Robert Busch, MD;Robin S. Goland, MD;Kimberly Simmons, MD;Teresa Quattrin, MD

February 3rd 2023

Robert Busch, MD, and Robin S. Goland, MD, review the prevalence and pathophysiology of type 1 diabetes.

Key Takeaways for Screening and Diagnosis of T1D

Tina Q Tan, MD;Kimberly Simmons, MD

January 12th 2023

Kimberly Simmons, MD, provides resources for patients with T1D, and key takeaways for pediatricians screening for and diagnosing T1D in pediatric patients.

Blood Glucose Monitoring in T1D

Tina Q Tan, MD;Kimberly Simmons, MD

January 12th 2023

Tina Q. Tan, MD, and Kimberly Simmons, MD, discuss improved methods of monitoring blood glucose levels in patients with type 1 diabetes.

Emerging Treatments in T1D

Tina Q Tan, MD;Kimberly Simmons, MD

January 5th 2023

Kimberly Simmons, MD, reviews a new drug in the pipeline for the treatment of pediatric type 1 diabetes.

Approaching T1D Screening Retesting

Tina Q Tan, MD;Kimberly Simmons, MD

January 5th 2023

Experts consider how often a patient with a family history of type 1 diabetes needs to be retested.

Lifestyle Management in T1D

Tina Q Tan, MD;Kimberly Simmons, MD

December 29th 2022

Tina Q Tan, MD, and Kimberly Simmons, MD, discuss lifestyle changes such as a balanced diet and glucose monitoring in the management of pediatric T1D.

Importance of Screening for T1D

Tina Q Tan, MD;Kimberly Simmons, MD

December 29th 2022

Tina Q Tan, MD, and Kimberly Simmons, MD, comment on early screening for pediatric T1D, screening options, and next steps once a child has tested positive for 2 or more autoantibodies.

Stages and Progression of T1D

Tina Q Tan, MD;Kimberly Simmons, MD

December 22nd 2022

Kimberly Simmons, MD, reviews stages 1, 2, and 3 of pediatric T1D progression.

Prevalence and Risk Factors of Pediatric Type 1 Diabetes (T1D)

Tina Q Tan, MD;Kimberly Simmons, MD

December 22nd 2022

Tina Q Tan, MD, and Kimberly Simmons, MD, provide an overview of the prevalence of type 1 diabetes (T1D) in pediatric patients as well as its risk factors.